Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence

Grants

Funding Acknowledgements

Dr Maria Garefalakis has undertaken clinical research sponsored by Organon, Pfizer, GlaxoSmithKline and Schering AG and has been sponsored by these companies to attend international meetings. She has received an honorarium for speaking at a symposium sponsored by Astrazeneca.Dr Martha Hickey has been reimbursed for attending symposia by Wyeth, Organon, and Novo Nordisk; has also received honoraria for speaking at symposia sponsored by pharmaceutical companies for national and international meetings from Novo Nordisk, Wyeth, Schering and Organon; and is undertaking clinical research sponsored by Organon, Pfizer and Schering AG. She has received unrestricted educational grants from Astra Zeneca and Organon